BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Medicine Reviews 2005;9:269-310. [DOI: 10.1016/j.smrv.2005.03.004] [Cited by in Crossref: 234] [Cited by in F6Publishing: 147] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Luo G, Zhang J, Lin L, Mignot EJ. Characterization of T cell receptors reactive to HCRTNH2, pHA273-287, and NP17-31 in control and narcolepsy patients. Proc Natl Acad Sci U S A 2022;119:e2205797119. [PMID: 35914171 DOI: 10.1073/pnas.2205797119] [Reference Citation Analysis]
2 Pizza F, Barateau L, Dauvilliers Y, Plazzi G. The orexin story, sleep and sleep disturbances. J Sleep Res 2022;:e13665. [PMID: 35698789 DOI: 10.1111/jsr.13665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Akyildiz UO, Tezer FI, Koc G, Ismailogullari S, Demir AB, Ak AK, Sunter G, Kara KA, Berktas DT, Sahin A, Azman F, Akcay BD, Gok DK, Yilmaz H, Agan K, Bekmezci Y, Yetkin S, Aksu M, Karadeniz D, Senel GB. The REM-sleep related characteristics of narcolepsy: A nation-wide multi-center study in Turkey, the REMCON study. Sleep Medicine 2022. [DOI: 10.1016/j.sleep.2022.03.025] [Reference Citation Analysis]
4 Demidova A, Kahl E, Fendt M. Orexin deficiency affects sensorimotor gating and its amphetamine-induced impairment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110517] [Reference Citation Analysis]
5 Sassower KC. From REM to orexin: clinical progress in narcolepsy - was it worth the wait? was it worth the "weight?". Arq Neuropsiquiatr 2021;79:757-8. [PMID: 34669824 DOI: 10.1590/0004-282X-anp-2021-E009] [Reference Citation Analysis]
6 Wheeler YS, Heaton K. Distinguishing the Diagnosis and Management of Sleep Disturbance and Sleep Disorders in Multiple Sclerosis. Nurs Clin North Am 2021;56:157-74. [PMID: 34023113 DOI: 10.1016/j.cnur.2021.02.001] [Reference Citation Analysis]
7 Dye TJ, Simakajornboon N. Narcolepsy in Children: Sleep disorders in children, A rapidly evolving field seeking consensus. Pediatr Pulmonol 2021. [PMID: 34021733 DOI: 10.1002/ppul.25512] [Reference Citation Analysis]
8 Santifort KM, Ives EJ, Fenn J, Raimondi F, Lourinho F, Mandigers PJJ, Bergknut N. Suspected acquired narcolepsy in 8 dogs. J Vet Intern Med 2021;35:1448-54. [PMID: 33960533 DOI: 10.1111/jvim.16116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dubessy AL, Tezenas du Montcel S, Viala F, Assouad R, Tiberge M, Papeix C, Lubetzki C, Clanet M, Arnulf I, Stankoff B. Association of Central Hypersomnia and Fatigue in Patients With Multiple Sclerosis: A Polysomnographic Study. Neurology 2021;97:e23-33. [PMID: 33931534 DOI: 10.1212/WNL.0000000000012120] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang Y, Ren R, Yang L, Zhang H, Shi Y, Sanford LD, Tang X. Polysomnographic nighttime features of narcolepsy: A systematic review and meta-analysis. Sleep Med Rev 2021;58:101488. [PMID: 33934047 DOI: 10.1016/j.smrv.2021.101488] [Reference Citation Analysis]
11 Cataldi M, Arnaldi D, Tucci V, De Carli F, Patti G, Napoli F, Pace M, Maghnie M, Nobili L. Sleep disorders in Prader-Willi syndrome, evidence from animal models and humans. Sleep Med Rev 2021;57:101432. [PMID: 33567377 DOI: 10.1016/j.smrv.2021.101432] [Reference Citation Analysis]
12 Berteotti C, Liguori C, Pace M. Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far-reaching implications for neurological disorders. Eur J Neurosci 2021;53:1136-54. [PMID: 33290595 DOI: 10.1111/ejn.15077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Malter M, Neuneier J, Triller A, Kallweit U. [Narcolepsy in adults: Definition, etiology and treatment]. Fortschr Neurol Psychiatr 2021;89:103-13. [PMID: 33339064 DOI: 10.1055/a-1244-2612] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Imanishi A, Kawazoe T, Hamada Y, Kumagai T, Tsutsui K, Sakai N, Eto K, Noguchi A, Shimizu T, Takahashi T, Han G, Mishima K, Kanbayashi T, Kondo H. Early detection of Niemann-pick disease type C with cataplexy and orexin levels: continuous observation with and without Miglustat. Orphanet J Rare Dis 2020;15:269. [PMID: 32993765 DOI: 10.1186/s13023-020-01531-4] [Reference Citation Analysis]
15 Lammers GJ, Bassetti CL, Dolenc-groselj L, Jennum PJ, Kallweit U, Khatami R, Lecendreux M, Manconi M, Mayer G, Partinen M, Plazzi G, Reading PJ, Santamaria J, Sonka K, Dauvilliers Y. Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts. Sleep Medicine Reviews 2020;52:101306. [DOI: 10.1016/j.smrv.2020.101306] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
16 Monderer R, Ahmed IM, Thorpy M. Evaluation of the Sleepy Patient. Sleep Medicine Clinics 2020;15:155-66. [DOI: 10.1016/j.jsmc.2020.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Takenoshita S, Nishino S. Pharmacologic Management of Excessive Daytime Sleepiness. Sleep Med Clin 2020;15:177-94. [PMID: 32386693 DOI: 10.1016/j.jsmc.2020.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
18 Heidbreder A, Dirks C, Ramm M. Therapy for Cataplexy. Curr Treat Options Neurol 2020;22. [DOI: 10.1007/s11940-020-0619-5] [Reference Citation Analysis]
19 Li SB, de Lecea L. The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology 2020;167:107993. [PMID: 32135427 DOI: 10.1016/j.neuropharm.2020.107993] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
20 Calva CB, Fayyaz H, Fadel JR. Effects of Intranasal Orexin-A (Hypocretin-1) Administration on Neuronal Activation, Neurochemistry, and Attention in Aged Rats. Front Aging Neurosci 2019;11:362. [PMID: 32038222 DOI: 10.3389/fnagi.2019.00362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Berntsson SG, Kristoffersson A, Daniilidou M, Dahl N, Ekström C, Semnic R, Markström A, Niemelä V, Partinen M, Hallböök F, Landtblom AM. Aniridia with PAX6 mutations and narcolepsy. J Sleep Res 2020;29:e12982. [PMID: 31943460 DOI: 10.1111/jsr.12982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Antelmi E, Pizza F, Franceschini C, Ferri R, Plazzi G. REM sleep behavior disorder in narcolepsy: A secondary form or an intrinsic feature? Sleep Med Rev 2020;50:101254. [PMID: 31931470 DOI: 10.1016/j.smrv.2019.101254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
23 Yukitake H, Fujimoto T, Ishikawa T, Suzuki A, Shimizu Y, Rikimaru K, Ito M, Suzuki M, Kimura H. TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice. Pharmacology Biochemistry and Behavior 2019;187:172794. [DOI: 10.1016/j.pbb.2019.172794] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
24 Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, Khatami R, Koning F, Kornum BR, Lammers GJ, Liblau RS, Luppi PH, Mayer G, Pollmächer T, Sakurai T, Sallusto F, Scammell TE, Tafti M, Dauvilliers Y. Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 2019;15:519-39. [DOI: 10.1038/s41582-019-0226-9] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 37.7] [Reference Citation Analysis]
25 Peter-derex L. Patologie del sonno. EMC - Neurologia 2019;19:1-17. [DOI: 10.1016/s1634-7072(19)42492-6] [Reference Citation Analysis]
26 Hamada Y, Takata T, Kawakita R, Kobara H, Okada M, Tamiya T, Kanbayashi T, Touge T, Deguchi K, Masaki T. Orexin secretion abnormality involved in excessive somnolence in CNS lymphoma without hypothalamic lesions. J Clin Neurosci 2019;64:6-7. [PMID: 30962060 DOI: 10.1016/j.jocn.2019.03.066] [Reference Citation Analysis]
27 Huang B, Xu T, Wang Z, Chen K, Zhang J, Zhao Z, Zhuang J, Wu H. The clinical characteristics of cataplectic attack in narcolepsy type 1. Sleep Med 2021;77:261-9. [PMID: 31607435 DOI: 10.1016/j.sleep.2019.03.015] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Foschi M, Rizzo G, Liguori R, Avoni P, Mancinelli L, Lugaresi A, Ferini-strambi L. Sleep-related disorders and their relationship with MRI findings in multiple sclerosis. Sleep Medicine 2019;56:90-7. [DOI: 10.1016/j.sleep.2019.01.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
29 Lima FCB, do Nascimento Junior EB, Teixeira SS, Coelho FM, Oliveira GDP. Thinking outside the box: cataplexy without narcolepsy. Sleep Med 2019;61:118-21. [PMID: 31427075 DOI: 10.1016/j.sleep.2019.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Sakai N, Matsumura M, Lin L, Mignot E, Nishino S. HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy. Sci Rep 2019;9:477. [PMID: 30679597 DOI: 10.1038/s41598-018-36942-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
31 Sforza E, Hupin D, Roche F. Mononucleosis: A Possible Cause of Idiopathic Hypersomnia. Front Neurol 2018;9:922. [PMID: 30429823 DOI: 10.3389/fneur.2018.00922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ono H, Kanbayashi T, Imanishi A, Ayabe T, Sagawa Y, Tsutsui K, Ohmori Y, Takeshima M, Nishino S, Shimizu T. Clinical characteristics of symptomatic narcolepsy or hypersomnia: an analysis of 182 consecutive cases with neurological disorders associated with hypersomnolence. Sleep Biol Rhythms 2019;17:123-40. [DOI: 10.1007/s41105-018-0186-2] [Reference Citation Analysis]
33 Miyagawa T, Khor SS, Toyoda H, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Ariyoshi Y, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Ikegami A, Wada Y, Takami M, Higashiyama Y, Miyake R, Kondo H, Fujimura Y, Tamura Y, Taniyama Y, Omata N, Tanaka Y, Moriya S, Furuya H, Kato M, Kawamura Y, Otowa T, Miyashita A, Kojima H, Saji H, Shimada M, Yamasaki M, Kobayashi T, Misawa R, Shigematsu Y, Kuwano R, Sasaki T, Ishigooka J, Wada Y, Tsuruta K, Chiba S, Tanaka F, Yamada N, Okawa M, Kuroda K, Kume K, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K. A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia. J Hum Genet 2018;63:1259-67. [PMID: 30266950 DOI: 10.1038/s10038-018-0518-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Kallweit U, Bassetti CLA, Oberholzer M, Fronczek R, Béguin M, Strub M, Lammers GJ. Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis : Six new cases and a literature review. J Neurol 2018;265:2071-8. [PMID: 29974206 DOI: 10.1007/s00415-018-8949-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
35 Weil AG, Muir K, Hukin J, Desautels A, Martel V, Perreault S. Narcolepsy and Hypothalamic Region Tumors: Presentation and Evolution. Pediatric Neurology 2018;84:27-31. [DOI: 10.1016/j.pediatrneurol.2017.12.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Wang C, Wang Q, Ji B, Pan Y, Xu C, Cheng B, Bai B, Chen J. The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. Front Mol Neurosci 2018;11:220. [PMID: 30002617 DOI: 10.3389/fnmol.2018.00220] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 13.8] [Reference Citation Analysis]
37 Dauvilliers Y, Barateau L. Narcolepsy and Other Central Hypersomnias. Continuum (Minneap Minn) 2017;23:989-1004. [PMID: 28777172 DOI: 10.1212/CON.0000000000000492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
38 Sarkanen T, Alakuijala A, Julkunen I, Partinen M. Narcolepsy Associated with Pandemrix Vaccine. Curr Neurol Neurosci Rep 2018;18:43. [PMID: 29855798 DOI: 10.1007/s11910-018-0851-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
39 Takenoshita S, Sakai N, Chiba Y, Matsumura M, Yamaguchi M, Nishino S. An overview of hypocretin based therapy in narcolepsy. Expert Opinion on Investigational Drugs 2018;27:389-406. [DOI: 10.1080/13543784.2018.1459561] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
40 Postiglione E, Antelmi E, Pizza F, Lecendreux M, Dauvilliers Y, Plazzi G. The clinical spectrum of childhood narcolepsy. Sleep Medicine Reviews 2018;38:70-85. [DOI: 10.1016/j.smrv.2017.04.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
41 Kim P, During E, Miglis M. A Case of Narcolepsy Type 2 and Postural Tachycardia Syndrome Secondary to Lesions of the Thalamus and Amygdala. J Clin Sleep Med 2018;14:479-81. [PMID: 29458703 DOI: 10.5664/jcsm.7006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
42 Lorenzoni PJ, Werneck LC, Crippa ACS, Zanatta A, Kay CSK, Silvado CES, Scola RH. Is there a relationship between narcolepsy, multiple sclerosis and HLA-DQB1*06:02? Arq Neuropsiquiatr 2017;75:345-8. [PMID: 28658402 DOI: 10.1590/0004-282X20170063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
43 Takenoshita S, Nishino S. Pharmacologic Management of Excessive Daytime Sleepiness. Sleep Med Clin 2017;12:461-78. [PMID: 28778242 DOI: 10.1016/j.jsmc.2017.03.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
44 Bae EK, Oh DA, Yoon BN. Symptomatic Narcolepsy in Sjögren Syndrome. J Rheumatol 2017;44:852-3. [PMID: 28572475 DOI: 10.3899/jrheum.160940] [Reference Citation Analysis]
45 Monderer R, Ahmed IM, Thorpy M. Evaluation of the Sleepy Patient: Differential Diagnosis. Sleep Med Clin 2017;12:301-12. [PMID: 28778229 DOI: 10.1016/j.jsmc.2017.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
46 Schmid S, Hodshon A, Olin S, Pfeiffer I, Hecht S. Pituitary Macrotumor Causing Narcolepsy-Cataplexy in a Dachshund. J Vet Intern Med 2017;31:545-9. [PMID: 28090682 DOI: 10.1111/jvim.14640] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Giannoccaro MP, Waters P, Pizza F, Liguori R, Plazzi G, Vincent A. Antibodies Against Hypocretin Receptor 2 Are Rare in Narcolepsy. Sleep 2017;40. [DOI: 10.1093/sleep/zsw056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
48 Renna R, Koudriavtseva T, Renna A, Renna S. Narcolepsy in midbrain structural lesion. Ann Indian Acad Neurol 2016;19:404-5. [PMID: 27570400 DOI: 10.4103/0972-2327.186844] [Reference Citation Analysis]
49 González-Platas M, González-Platas J, Bermúdez-Hernández M, Pérez-Martín MY, Croissier-Elías C, Pérez-Lorensu PJ. Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population. J Clin Sleep Med 2016;12:805-11. [PMID: 26951408 DOI: 10.5664/jcsm.5874] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
50 Sansa G, Gavaldà A, Gaig C, Monreal J, Ercilla G, Casamitjana R, Ribera G, Iranzo A, Santamaria J. Exploring the presence of narcolepsy in patients with schizophrenia. BMC Psychiatry 2016;16:177. [PMID: 27245445 DOI: 10.1186/s12888-016-0859-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
51 Kotterba S. [Sleep disorders in neurological diseases]. Nervenarzt 2015;86:759-70; quiz 771. [PMID: 26062945 DOI: 10.1007/s00115-014-4204-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
52 Viola-Saltzman M, Musleh C. Traumatic brain injury-induced sleep disorders. Neuropsychiatr Dis Treat 2016;12:339-48. [PMID: 26929626 DOI: 10.2147/NDT.S69105] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
53 Shehna A, Khan F, Sandhya KS. Radiation-induced secondary narcolepsy. Ann Indian Acad Neurol 2015;18:488-90. [PMID: 26713038 DOI: 10.4103/0972-2327.157257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Braley TJ, Chervin RD. A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis. Ther Adv Neurol Disord 2015;8:294-310. [PMID: 26600873 DOI: 10.1177/1756285615605698] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
55 Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 2015;38:1249-63. [PMID: 26062517 DOI: 10.1007/s40618-015-0312-9] [Cited by in Crossref: 306] [Cited by in F6Publishing: 253] [Article Influence: 43.7] [Reference Citation Analysis]
56 Veauthier C. Sleep Disorders in Multiple Sclerosis. Review. Curr Neurol Neurosci Rep 2015;15. [DOI: 10.1007/s11910-015-0546-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
57 Krahn LE, Hershner S, Loeding LD, Maski KP, Rifkin DI, Selim B, Watson NF. Quality measures for the care of patients with narcolepsy. J Clin Sleep Med 2015;11:335. [PMID: 25700880 DOI: 10.5664/jcsm.4554] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
58 Szabadi E. GHB for cataplexy: Possible mode of action. J Psychopharmacol 2015;29:744-9. [DOI: 10.1177/0269881115573807] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
59 Walter LM, Nixon GM, Davey MJ, Downie PA, Horne RS. Sleep and fatigue in pediatric oncology: A review of the literature. Sleep Med Rev 2015;24:71-82. [PMID: 25679070 DOI: 10.1016/j.smrv.2015.01.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
60 Ryu O, Ryu HU, Lee S. Symptomatic Narcolepsy and Generalized Seizures Following Surgery for Rathke’s Cleft Cyst. Sleep Med Res 2014;5:72-6. [DOI: 10.17241/smr.2014.5.2.72] [Reference Citation Analysis]
61 Nevsimalova S, Malinova V. Cataplexy and Sleep Disorders in Niemann-Pick Type C Disease. Curr Neurol Neurosci Rep 2015;15. [DOI: 10.1007/s11910-014-0522-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
62 Kosse C, Burdakov D. A unifying computational framework for stability and flexibility of arousal. Front Syst Neurosci 2014;8:192. [PMID: 25368557 DOI: 10.3389/fnsys.2014.00192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
63 Klein G, Burghaus L, Vaillant M, Pieri V, Fink GR, Diederich N. Dysautonomia in narcolepsy: evidence by questionnaire assessment. J Clin Neurol 2014;10:314-9. [PMID: 25324880 DOI: 10.3988/jcn.2014.10.4.314] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
64 Nevsimalova S. The Diagnosis and Treatment of Pediatric Narcolepsy. Curr Neurol Neurosci Rep 2014;14. [DOI: 10.1007/s11910-014-0469-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
65 Baumann CR, Mignot E, Lammers GJ, Overeem S, Arnulf I, Rye D, Dauvilliers Y, Honda M, Owens JA, Plazzi G, Scammell TE. Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. Sleep 2014;37:1035-42. [PMID: 24882898 DOI: 10.5665/sleep.3756] [Cited by in Crossref: 92] [Cited by in F6Publishing: 72] [Article Influence: 11.5] [Reference Citation Analysis]
66 Carroll C, Landau ME. Effects of pontine lesions on REM sleep. Curr Neurol Neurosci Rep 2014;14:460. [PMID: 24828197 DOI: 10.1007/s11910-014-0460-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
67 Leschziner G. Narcolepsy: a clinical review. Pract Neurol 2014;14:323-31. [PMID: 24830461 DOI: 10.1136/practneurol-2014-000837] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
68 Moghadam KK, Pizza F, La Morgia C, Franceschini C, Tonon C, Lodi R, Barboni P, Seri M, Ferrari S, Liguori R, Donadio V, Parchi P, Cornelio F, Inzitari D, Mignarri A, Capocchi G, Dotti MT, Winkelmann J, Lin L, Mignot E, Carelli V, Plazzi G. Narcolepsy is a common phenotype in HSAN IE and ADCA-DN. Brain 2014;137:1643-55. [DOI: 10.1093/brain/awu069] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
69 Martínez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, De Andrés C, Fernández-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res 2014;23:414-9. [PMID: 24645699 DOI: 10.1111/jsr.12143] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
70 Donadio V, Liguori R, Vandi S, Giannoccaro MP, Pizza F, Leta V, Plazzi G. Sympathetic and cardiovascular changes during sleep in narcolepsy with cataplexy patients. Sleep Med 2014;15:315-21. [PMID: 24503475 DOI: 10.1016/j.sleep.2013.12.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
71 Rousselle C, des Portes V, Berlier P, Mottolese C. Pineal region tumors: Clinical symptoms and syndromes. Neurochirurgie 2015;61:106-12. [PMID: 24439798 DOI: 10.1016/j.neuchi.2013.08.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
72 Veauthier C, Paul F. Sleep disorders in multiple sclerosis and their relationship to fatigue. Sleep Medicine 2014;15:5-14. [DOI: 10.1016/j.sleep.2013.08.791] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 9.6] [Reference Citation Analysis]
73 Barun B. Pathophysiological background and clinical characteristics of sleep disorders in multiple sclerosis. Clinical Neurology and Neurosurgery 2013;115:S82-5. [DOI: 10.1016/j.clineuro.2013.09.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
74 Miller J, Wagner M. Prader-Willi Syndrome and Sleep-Disordered Breathing. Pediatr Ann 2013;42. [DOI: 10.3928/00904481-20130924-10] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
75 Peraita-adrados R, Lammers GJ, De Andrés C, Santamaría J, Vicario JL, Tafti M. A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms? Sleep Medicine 2013;14:695-6. [DOI: 10.1016/j.sleep.2013.03.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
76 Feneberg E, Steinacker P, Lehnert S, Böhm B, Mayer G, Otto M. Elevated glial fibrillary acidic protein levels in the cerebrospinal fluid of patients with narcolepsy. Sleep Medicine 2013;14:692-4. [DOI: 10.1016/j.sleep.2013.04.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
77 Çoban A, Bilgiç B, Lohmann E, Küçükali Cİ, Benbir G, Karadeniz D, Hanagasi HA, Tüzün E, Gürvit H. Reduced orexin-A levels in frontotemporal dementia: possible association with sleep disturbance. Am J Alzheimers Dis Other Demen 2013;28:606-11. [PMID: 23813609 DOI: 10.1177/1533317513494453] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
78 Rye DB, Bliwise DL, Parker K, Trotti LM, Saini P, Fairley J, Freeman A, Garcia PS, Owens MJ, Ritchie JC, Jenkins A. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci Transl Med 2012;4:161ra151. [PMID: 23175709 DOI: 10.1126/scitranslmed.3004685] [Cited by in Crossref: 104] [Cited by in F6Publishing: 81] [Article Influence: 11.6] [Reference Citation Analysis]
79 Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun 2013;43:26-31. [PMID: 23497937 DOI: 10.1016/j.jaut.2013.02.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
80 Xiong X, White RE, Xu L, Yang L, Sun X, Zou B, Pascual C, Sakurai T, Giffard RG, Xie XS. Mitigation of murine focal cerebral ischemia by the hypocretin/orexin system is associated with reduced inflammation. Stroke 2013;44:764-70. [PMID: 23349191 DOI: 10.1161/STROKEAHA.112.681700] [Cited by in Crossref: 46] [Cited by in F6Publishing: 25] [Article Influence: 5.1] [Reference Citation Analysis]
81 Lunde HM, Bjorvatn B, Myhr KM, Bø L. Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review. Acta Neurol Scand Suppl 2013;:24-30. [PMID: 23190288 DOI: 10.1111/ane.12046] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
82 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness: 2012 Update. Sleep Med Clin 2012;7:469-86. [PMID: 23162386 DOI: 10.1016/j.jsmc.2012.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
83 Nishino S, Deguzman C, Yamadera W, Chiba S, Kanbayashi T. Neurochemistry and Biomarkers of Narcolepsy and Other Primary and Secondary Hypersomnias. Sleep Medicine Clinics 2012;7:233-48. [DOI: 10.1016/j.jsmc.2012.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
84 Bassetti CL. Primary and Secondary Neurogenic Hypersomnias. Sleep Medicine Clinics 2012;7:249-61. [DOI: 10.1016/j.jsmc.2012.03.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
85 Overeem S, Reading P, Bassetti CL. Narcolepsy. Sleep Medicine Clinics 2012;7:263-81. [DOI: 10.1016/j.jsmc.2012.03.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Dyken ME, Afifi AK, Lin-Dyken DC. Sleep-related problems in neurologic diseases. Chest 2012;141:528-44. [PMID: 22315121 DOI: 10.1378/chest.11-0773] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
87 Partinen M, Saarenpää-Heikkilä O, Ilveskoski I, Hublin C, Linna M, Olsén P, Nokelainen P, Alén R, Wallden T, Espo M, Rusanen H, Olme J, Sätilä H, Arikka H, Kaipainen P, Julkunen I, Kirjavainen T. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012;7:e33723. [PMID: 22470463 DOI: 10.1371/journal.pone.0033723] [Cited by in Crossref: 295] [Cited by in F6Publishing: 232] [Article Influence: 29.5] [Reference Citation Analysis]
88 Ohayon MM, Dauvilliers Y, Reynolds CF 3rd. Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology. Arch Gen Psychiatry 2012;69:71-9. [PMID: 22213791 DOI: 10.1001/archgenpsychiatry.2011.1240] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
89 Schaer M, Poryazova R, Schwartz S, Bassetti CL, Baumann CR. Cortical morphometry in narcolepsy with cataplexy: Cortical morphometry in narcolepsy with cataplexy. Journal of Sleep Research 2012;21:487-94. [DOI: 10.1111/j.1365-2869.2012.01000.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
90 Darlix A, Mathey G, Monin ML, Sauvée M, Braun M, Schaff JL, Debouverie M. [Hypothalamic involvement in multiple sclerosis]. Rev Neurol (Paris) 2012;168:434-43. [PMID: 22136879 DOI: 10.1016/j.neurol.2011.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
91 Pizza F, Vetrugno R, Antelmi E, Pierangeli G, Montagna P, Cortelli P. Narcoleptic-like hypersomnia and inverted circadian rhythm of body core temperature after traumatic brain injury involving the hypothalamus. Sleep Med 2011;12:1044-5. [PMID: 22033119 DOI: 10.1016/j.sleep.2011.06.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
92 Caminero A, Bartolomé M. Sleep disturbances in multiple sclerosis. Journal of the Neurological Sciences 2011;309:86-91. [DOI: 10.1016/j.jns.2011.07.015] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
93 Deguchi K, Kono S, Deguchi S, Morimoto N, Ikeda M, Kurata T, Ikeda Y, Matsuura T, Kanbayashi T, Takahashi T, Abe K. A patient with anti-aquaporin 4 antibody presenting hypersomnolence as the initial symptom and symmetrical hypothalamic lesions. J Neurol Sci 2012;312:18-20. [PMID: 21917270 DOI: 10.1016/j.jns.2011.08.031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
94 Akintomide GS, Rickards H. Narcolepsy: a review. Neuropsychiatr Dis Treat 2011;7:507-18. [PMID: 21931493 DOI: 10.2147/NDT.S23624] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
95 Kanbayashi T, Sagawa Y, Takemura F, Ito S, Tsutsui K, Hishikawa Y, Nishino S. The Pathophysiologic Basis of Secondary Narcolepsy and Hypersomnia. Curr Neurol Neurosci Rep 2011;11:235-41. [DOI: 10.1007/s11910-011-0178-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
96 Haddad F, Anouti S, Maalouly G, Koussa S. [Narcolepsy associated with systemic lupus erythematosus]. Rev Med Interne 2011;32:e114-5. [PMID: 21145142 DOI: 10.1016/j.revmed.2010.10.352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness. Sleep Med Clin 2010;5:513-28. [PMID: 21278831 DOI: 10.1016/j.jsmc.2010.08.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
98 Siclari F, Khatami R, Urbaniok F, Nobili L, Mahowald MW, Schenck CH, Cramer Bornemann MA, Bassetti CL. Violence in sleep. Brain 2010;133:3494-509. [DOI: 10.1093/brain/awq296] [Cited by in Crossref: 61] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
99 Kim JW, Shin H, Kim E, Koo Y, Choi B, Park KS, Jeong D. Characteristic time scales of electroencephalograms of narcoleptic patients and healthy controls. Computers in Biology and Medicine 2010;40:831-8. [DOI: 10.1016/j.compbiomed.2010.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
100 Mihara Y, Dohi K, Yofu S, Nakamachi T, Ohtaki H, Shioda S, Aruga T. Expression and localization of the orexin-1 receptor (OX1R) after traumatic brain injury in mice. J Mol Neurosci 2011;43:162-8. [PMID: 20803175 DOI: 10.1007/s12031-010-9438-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
101 Haq IZ, Naidu Y, Reddy P, Chaudhuri KR. Narcolepsy in Parkinson's disease. Expert Rev Neurother 2010;10:879-84. [PMID: 20518604 DOI: 10.1586/ern.10.56] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
102 Marrie RA, Horwitz RI. Emerging effects of comorbidities on multiple sclerosis. Lancet Neurol 2010;9:820-8. [PMID: 20650403 DOI: 10.1016/S1474-4422(10)70135-6] [Cited by in Crossref: 112] [Cited by in F6Publishing: 44] [Article Influence: 9.3] [Reference Citation Analysis]
103 Zaharna M, Dimitriu A, Guilleminault C. Expert opinion on pharmacotherapy of narcolepsy. Expert Opin Pharmacother 2010;11:1633-45. [PMID: 20426704 DOI: 10.1517/14656566.2010.484021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
104 Okuro M, Fujiki N, Kotorii N, Ishimaru Y, Sokoloff P, Nishino S. Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice. Sleep 2010;33:930-42. [PMID: 20614853 DOI: 10.1093/sleep/33.7.930] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
105 Ritchie C, Okuro M, Kanbayashi T, Nishino S. Hypocretin ligand deficiency in narcolepsy: recent basic and clinical insights. Curr Neurol Neurosci Rep 2010;10:180-9. [PMID: 20425033 DOI: 10.1007/s11910-010-0100-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
106 Alóe F, Alves RC, Araújo JF, Azevedo A, Bacelar A, Bezerra M, Bittencourt LR, Bustamante G, Cardoso TA, Eckeli AL, Fernandes RM, Goulart L, Pradella-Hallinan M, Hasan R, Sander HH, Pinto LR Jr, Lopes MC, Minhoto GR, Moraes W, Moreira GA, Pachito D, Pedrazolli M, Poyares D, Prado L, Rizzo G, Rodrigues RN, Roitman I, Silva AB, Tavares SM. [Brazilian guidelines for the diagnosis of narcolepsy]. Braz J Psychiatry 2010;32:294-304. [PMID: 20585744 DOI: 10.1590/s1516-44462010005000014] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
107 Berthold-Losleben M, Himmerich H. The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology. Curr Neuropharmacol 2008;6:193-202. [PMID: 19506720 DOI: 10.2174/157015908785777238] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
108 Nishino S, Okuro M. Emerging treatments for narcolepsy and its related disorders. Expert Opin Emerg Drugs 2010;15:139-58. [PMID: 20166851 DOI: 10.1517/14728210903559852] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
109 Rosen G, Brand SR. Sleep in children with cancer: case review of 70 children evaluated in a comprehensive pediatric sleep center. Support Care Cancer 2011;19:985-94. [DOI: 10.1007/s00520-010-0921-y] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
110 Cao M. Advances in narcolepsy. Med Clin North Am 2010;94:541-55. [PMID: 20451031 DOI: 10.1016/j.mcna.2010.02.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
111 Brass SD, Duquette P, Proulx-therrien J, Auerbach S. Sleep disorders in patients with multiple sclerosis. Sleep Medicine Reviews 2010;14:121-9. [DOI: 10.1016/j.smrv.2009.07.005] [Cited by in Crossref: 103] [Cited by in F6Publishing: 76] [Article Influence: 8.6] [Reference Citation Analysis]
112 Papuć E, Stelmasiak Z, Grieb P, Paweł G, Rejdak K. CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients. Neurosci Lett 2010;474:9-12. [PMID: 20193740 DOI: 10.1016/j.neulet.2010.02.062] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
113 Nishino S, Okuro M, Kotorii N, Anegawa E, Ishimaru Y, Matsumura M, Kanbayashi T. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol (Oxf) 2010;198:209-22. [PMID: 19555382 DOI: 10.1111/j.1748-1716.2009.02012.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
114 Compta Y, Santamaria J, Ratti L, Tolosa E, Iranzo A, Muñoz E, Valldeoriola F, Casamitjana R, Ríos J, Marti MJ. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia. Brain 2009;132:3308-17. [PMID: 19858078 DOI: 10.1093/brain/awp263] [Cited by in Crossref: 86] [Cited by in F6Publishing: 72] [Article Influence: 7.2] [Reference Citation Analysis]
115 Merino-Andréu M, Martínez-Bermejo A. [Narcolepsy with and without cataplexy: an uncommon disabling and unrecognized disease]. An Pediatr (Barc) 2009;71:524-34. [PMID: 19892609 DOI: 10.1016/j.anpedi.2009.07.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
116 Didato G, Nobili L. Treatment of narcolepsy. Expert Rev Neurother 2009;9:897-910. [PMID: 19496692 DOI: 10.1586/ern.09.29] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
117 Mamelak M. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Prog Neurobiol 2009;89:193-219. [PMID: 19654034 DOI: 10.1016/j.pneurobio.2009.07.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
118 Smith RJ, See RE, Aston-Jones G. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur J Neurosci 2009;30:493-503. [PMID: 19656173 DOI: 10.1111/j.1460-9568.2009.06844.x] [Cited by in Crossref: 157] [Cited by in F6Publishing: 151] [Article Influence: 12.1] [Reference Citation Analysis]
119 Kim JW, Shin HB, Robinson PA. Quantitative study of the sleep onset period via detrended fluctuation analysis: normal vs. narcoleptic subjects. Clin Neurophysiol 2009;120:1245-51. [PMID: 19467617 DOI: 10.1016/j.clinph.2009.04.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
120 Nevsimalova S. Narcolepsy in childhood. Sleep Medicine Reviews 2009;13:169-80. [DOI: 10.1016/j.smrv.2008.04.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
121 Vetrugno R, Stecchi S, Plazzi G, Lodi R, D’angelo R, Alessandria M, Cortelli P, Montagna P. Narcolepsy-like syndrome in multiple sclerosis. Sleep Medicine 2009;10:389-91. [DOI: 10.1016/j.sleep.2008.03.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
122 Rosen GM, Shor AC, Geller TJ. Sleep in children with cancer. Curr Opin Pediatr 2008;20:676-81. [PMID: 19023918 DOI: 10.1097/mop.0b013e328312c7ad] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
123 Ji T, Kotagal S. A 15-year-old with drop attacks and unsteadiness while descending stairs. Semin Pediatr Neurol 2008;15:174-7. [PMID: 19073322 DOI: 10.1016/j.spen.2008.10.007] [Reference Citation Analysis]
124 Peterson PC, Husain AM. Pediatric narcolepsy. Brain and Development 2008;30:609-23. [DOI: 10.1016/j.braindev.2008.02.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
125 Rosen GM. Sleep and Wakefulness in Children with Brain Tumors. Sleep Medicine Clinics 2008;3:455-67. [DOI: 10.1016/j.jsmc.2008.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
126 Hauw JJ, Hausser-Hauw C, Hasboun D, Seilhean D. [The neuropathology of sleep in human neurodegenerative diseases]. Rev Neurol (Paris) 2008;164:669-82. [PMID: 18760429 DOI: 10.1016/j.neurol.2008.07.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
127 Dauvilliers Y, Arnulf I. Narcolepsie avec cataplexie. Revue Neurologique 2008;164:634-45. [DOI: 10.1016/j.neurol.2007.08.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
128 Bourgin P, Zeitzer JM, Mignot E. CSF hypocretin-1 assessment in sleep and neurological disorders. The Lancet Neurology 2008;7:649-62. [DOI: 10.1016/s1474-4422(08)70140-6] [Cited by in Crossref: 93] [Cited by in F6Publishing: 26] [Article Influence: 6.6] [Reference Citation Analysis]
129 Dauvilliers Y, Bisser S, Chapotot F, Vatunga G, Cespuglio R, Josenando T, Buguet A. Hypocretin and human African trypanosomiasis. Sleep 2008;31:348-54. [PMID: 18363311 DOI: 10.1093/sleep/31.3.348] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
130 Laloux C, Derambure P, Houdayer E, Jacquesson JM, Bordet R, Destée A, Monaca C. Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice. J Sleep Res 2008;17:101-10. [PMID: 18275560 DOI: 10.1111/j.1365-2869.2008.00625.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
131 Overeem S, Black JL 3rd, Lammers GJ. Narcolepsy: immunological aspects. Sleep Med Rev 2008;12:95-107. [PMID: 18291691 DOI: 10.1016/j.smrv.2007.07.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
132 Nozaki H, Shimohata T, Kanbayashi T, Sagawa Y, Katada S, Satoh M, Onodera O, Tanaka K, Nishizawa M. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions. Sleep Med 2009;10:253-5. [PMID: 18226957 DOI: 10.1016/j.sleep.2007.11.022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
133 Nishino S. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders. Expert Opinion on Investigational Drugs 2007;16:1785-97. [DOI: 10.1517/13543784.16.11.1785] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
134 Billiard M. Diagnosis of narcolepsy and idiopathic hypersomnia. An update based on the International Classification of Sleep Disorders, 2nd edition. Sleep Medicine Reviews 2007;11:377-88. [DOI: 10.1016/j.smrv.2007.04.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
135 Sanger DJ, Soubrane C, Scatton B. New perspectives for the treatment of disorders of sleep and arousal. Ann Pharm Fr 2007;65:268-74. [PMID: 17652996 DOI: 10.1016/s0003-4509(07)90046-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
136 Dohi K, Ripley B, Fujiki N, Ohtaki H, Yamamoto T, Goto Y, Nakamachi T, Shioda S, Aruga T, Nishino S. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH). Regul Pept 2008;145:60-4. [PMID: 17868933 DOI: 10.1016/j.regpep.2007.08.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
137 Thorpy MJ. NARCOLEPSY: . CONTINUUM: Lifelong Learning in Neurology 2007;13:101-14. [DOI: 10.1212/01.con.0000275607.54292.85] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
138 Nishino S. Clinical and neurobiological aspects of narcolepsy. Sleep Med 2007;8:373-99. [PMID: 17470414 DOI: 10.1016/j.sleep.2007.03.008] [Cited by in Crossref: 122] [Cited by in F6Publishing: 85] [Article Influence: 8.1] [Reference Citation Analysis]
139 Mathis J, Hess CW, Bassetti C. Isolated mediotegmental lesion causing narcolepsy and rapid eye movement sleep behaviour disorder: a case evidencing a common pathway in narcolepsy and rapid eye movement sleep behaviour disorder. J Neurol Neurosurg Psychiatry 2007;78:427-9. [PMID: 17369596 DOI: 10.1136/jnnp.2006.099515] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
140 Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511. [PMID: 17292770 DOI: 10.1016/S0140-6736(07)60237-2] [Cited by in Crossref: 471] [Cited by in F6Publishing: 147] [Article Influence: 31.4] [Reference Citation Analysis]
141 Nishino S, Fujiki N. Neuropeptides as possible targets in sleep disorders. Expert Opin Ther Targets 2007;11:37-59. [PMID: 17150033 DOI: 10.1517/14728222.11.1.37] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
142 Waihrich ES, Rodrigues RN, Silveira HA, Fróes Fda F, Rocha GH. Comparative analysis of multiple sleep latency tests (MSLT) parameters and occurrence of dreaming in patients with daytime sleepiness of narcoleptic and non-narcoleptic origin. Arq Neuropsiquiatr 2006;64:958-62. [PMID: 17221004 DOI: 10.1590/s0004-282x2006000600014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
143 Knudsen S, Mikkelsen JD, Jennum P. Antibodies in narcolepsy–cataplexy patient serum bind to rat hypocretin neurons. NeuroReport 2007;18:77-9. [DOI: 10.1097/wnr.0b013e328010baad] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
144 Siegel JM, Boehmer LN. Narcolepsy and the hypocretin system--where motion meets emotion. Nat Clin Pract Neurol 2006;2:548-56. [PMID: 16990828 DOI: 10.1038/ncpneuro0300] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
145 Moore M, Allison D, Rosen CL. A Review of Pediatric Nonrespiratory Sleep Disorders. Chest 2006;130:1252-62. [DOI: 10.1378/chest.130.4.1252] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
146 Wurtman RJ. Narcolepsy and the hypocretins. Metabolism 2006;55:S36-9. [DOI: 10.1016/j.metabol.2006.07.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
147 Dohi K, Nishino S, Nakamachi T, Ohtaki H, Morikawa K, Takeda T, Shioda S, Aruga T. CSF orexin A concentrations and expressions of the orexin-1 receptor in rat hippocampus after cardiac arrest. Neuropeptides 2006;40:245-50. [PMID: 16930690 DOI: 10.1016/j.npep.2006.06.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
148 Nishino S. Narcolepsy. Sleep Medicine Clinics 2006;1:47-61. [DOI: 10.1016/j.jsmc.2005.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
149 Kilduff TS. Hypocretin/orexin: maintenance of wakefulness and a multiplicity of other roles. Sleep Med Rev 2005;9:227-30. [PMID: 15998593 DOI: 10.1016/j.smrv.2005.04.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]